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agricultural and/or waged work. As women are also the primary
carers in the family, the impact of tuberculosis is severe for indi-
vidual families as for society in general.
Evidence of gender disparities from studies in collaboration
betweenKarolinska Institutet andHanoiMedical University aswell
as fromthe literature include that TBdisease in somecontexts could
inﬂuence possibilities to marry, to stay married and even so via
proxy, since in particular women in a family with TB disease would
face barriers to marriage. Married women with TB may be at risk
of divorce, of their husband taking a second wife, or of being sent
to their natal homes. In Pakistan, marriage prospects as perceived
by parents inﬂuence treatment taking among unmarried children.
Conclusions: Gender dynamics are thus key factors affecting the
risk of a person becoming infected and developing tuberculosis
as well as his or her access to health information, health-seeking
behaviour and treatment outcome. In addition, gender norms and
gender inequality inﬂuence coping capacities and the social conse-
quences of having tuberculosis.
Future research needs include: Population-based studies in mul-
tiple settings together with sentinel surveillance activities are
recommended togetunbiaseddataonTB incidenceandprevalence.
Semi-active case-identiﬁcation in target populations, acknowledg-
ing the devastating effects of the interaction between gender and
HIV, eg. TB screening linked to PMTCTMore basic science initiatives
to investigate sex differences in immune response to infection and
determinants of disease development and the link to sex speciﬁc
hormone levels
http://dx.doi.org/10.1016/j.ijid.2014.03.558
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Sex differences in antiretroviral therapy efﬁcacy
and toxicity
J. Currier
UCLA, Los Angeles, CA, USA
The development of effective combination antiretroviral ther-
apy (ART) has transformed the management of HIV infection
over the past twenty years, yet many challenges remain. Globally
women comprise half of all people living with HIV, yet women
have been underrepresented in most clinical trials evaluating the
efﬁcacy and safety of ART. More recently several groups of inves-
tigators have designed and analyzed clinical trials with a goal of
evaluating sex difference in ART. These studies have suggested
differential rates of toxicity in women and men and some impor-
tant differences in response rates to standard treatments. This
presentation will review recent ﬁndings on sex differences in
the pharmacokinetics of protease inhibitors and non-nucleoside
reverse transcriptase inhibitors and highlight sex differences and
efﬁcacy from recent clinical trials. Finally research priorities in the
area of sex differences in HIV therapy will be suggested.
http://dx.doi.org/10.1016/j.ijid.2014.03.559
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Rickettsial diseases in Eastern Africa
A. Richards
Naval Medical Research Center, MD 20910-7500
USA, Silver Spring, MD, USA
Rickettsial diseases have been described in Eastern Africa
for over 50 years. These include: epidemic typhus (Rickettsia
prowazekii), murine typhus, (Rickettsia typhi) and Mediterranean
spotted fever also known as Kenyan tick typhus (Rickettsia conorii
subsp. conorii). Contemporary reports describe these samediseases
in addition to new rickettsiae and rickettsial diseases utilizing sero-
logical and molecular techniques. Some of the new agents and
diseases include: Rickettsia felis (ﬂea-borne spotted fever), Rick-
ettsia felis-like organisms (e.g. Candidatus Rickettsia asemboensis),
Rickettsia africae (African tick-bite fever), Rickettsia africae vari-
ants (e.g. Rickettsia sp. AVR4), Rickettsia aeschlimanni (an unnamed
tick-borne rickettsiosis), Rickettsia sibirica subsp. mongolitimonae
(lymphangitis-associated rickettsiosis), Rickettsia conorii subsp.
israelensis (Israeli spotted fever) and Candidatus Rickettsia kulagini.
These reports indicate that individuals residing in and thosevisiting
Eastern Africa are at risk of various rickettsial diseases. Unfortu-
nately, the dearth of comprehensive studies of the prevalence and
distribution of these rickettsiae or the incidence of the particular
rickettsioses hinder development of proper mitigation strategies.
http://dx.doi.org/10.1016/j.ijid.2014.03.560
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Rickettsioses in Africa: A paradigm of new or
emerging infectious diseases
D. Raoult
Faculté de la Mediterranée, Marseilles, France
Rickettsioses were considered 20 years ago as being rare dis-
eases with one species of Rickettsia transmitted by ticks, per
continent. Modern tools have been disrupting the perception of
the world of rickettsioses. The ﬁrst works were performed directly
on biting arthropods (ticks, ﬂeas, mites) that helped to identify a
number of microorganisms putatively involved in human diseases.
This difﬁculty to use classical tools for diagnosis in patients (such
as culture), prevented for a long time the identiﬁcation of human
cases. The development of molecular tools based on skin (biopsies
and swabs), and blood shows the huge frequency of rickettsioses.
In rural Asia, rickettsioses (scrub typhus and murine typhus) are
among the most frequent cause of unexplained prolonged fever.
In western and eastern Africa, rickettsioses (mainly R. felis) are the
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second cause of fever in rural areas after malaria. In many other
countries such studies have not yet been conducted. The identiﬁ-
cation of R. felis inmosquitoes questions their role in this disease. In
practice, because of their difﬁculty of diagnosis, rickettsioses were
considered, during the greater part of the 20th century, as rare dis-
eases. In reality, they are among the most commons in travellers
as a cause of fever, as well as in people, worldwide, in contact with
biting arthropods. Finally the current pitfall in this ﬁeld is the mis-
use of nested PCR that generate many false positive diagnosis and
should be avoided.
http://dx.doi.org/10.1016/j.ijid.2014.03.561
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Role of delocalized point of care diagnosis of
Rickettsioses in Senegal (Africa)
C.S. Sokhna
IRD-URMITE, Dakar, Senegal
A growing range of rapid diagnostic tests can be performed
at the Point-of-Care laboratory (POC) to elucidate the etiology of
febrile conditions. In tropical Africa, the spectrum of the bacterial
pathogens causing fever is poorly understood andmolecular-based
diagnostic laboratories are rare, the time lag between test results
and patient care is a critical point for treatment of disease. This
study provides the activity report of a POC in a rural Senegal vil-
lage, the information for its implementation in ﬁeld conditions and
describes themethodologyused toorganize the runningof this new
biomedical technology in response to the needs of rural African
healthcare. Based on accumulated knowledge of the repertoire of
microbial causes of febrile diseases in rural Senegal, we imple-
mented the rural POC in Dielmo (Senegal) to decrease the time lag
between test results and patient care. From February 2011 to May
2012, 563 blood specimens from febrile patients were collected
in Dielmo and Ndiop villages. All samples were screened for Bor-
relia spp., Coxiella burnetii, Tropheryma whipplei, Rickettsia conorii,
R. africae, R. felis, and Bartonella spp. We identiﬁed DNA from at
least one bacterial pathogen in 120/563 (21.3%) of the samples from
febrile patients. B. crociduraewas identiﬁed in 59 cases (10.5%), and
R. felis in 36 cases (6.4%), Bartonella spp. in 22/563 cases (4%), C. bur-
netii in 2 cases (0.3%) and T. whipplei in one patient (0.2%). R. africae
and R. conorii were not detected. Among 8 co-infected patients, 5
were co-infected by R. felis and B. crocidurae, 2 by B. crocidurae and
Bartonella spp., 1 by B. crocidurae and C. burnetii and 1 by R. felis
and B. quintana in 1. We report the proof of concept of POC in rural
tropical Africa. Diagnosing that 21.3% of acute infections can be
successfully treatedwith doxycycline should change the treatment
strategy for acute fevers in West Africa.
http://dx.doi.org/10.1016/j.ijid.2014.03.562
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Rickettsial disease in febrile patients in Africa
with or without malaria
O. Doumbo
Malaria Research and Training Center, Bamako, Mali
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Can pediatric HIV be eliminated?
G. Gray
University of Witwatersrand, Perinatal HIV Research
Unit, Johannesburg, South Africa
The World Health Organization (WHO) has called for the “vir-
tual elimination” of pediatricHIV. Virtual elimination, an ambitious
program encompasses the goals of reducing the number of new
child HIV infections by 90% by 2015 and to reduce perinatal trans-
mission to rates of less than 5%. To achieve this will require: 1)
efforts to decrease primary HIV infection in young women; 2) the
prevention of unintended pregnancies in HIV infected women; 3)
the reduction of perinatal transmission; 4) optimital care for fam-
ilies infected with HIV. This will require signiﬁcant resources at
a country level aimed at health systems strengthening, especially
in countries with a high burden of HIV. Improving access to con-
traception and universal HIV testing for women of child bearing
potential will be a critical component to achieving this. Ensuring
that all pregnant women attend antenatal care, receiving regular
HIV testing during pregnancy and timely triage into antiretrovi-
ral care without seepage will help to drive perinatal transmission
down. Preventing post-natal transmission through breastfeeding
and retention in care of both mother and infant are critical. This
talkwill look at the barriers and challenges to eliminating pediatric
HIV as well as looking at strategies for potential pediatric cure.
http://dx.doi.org/10.1016/j.ijid.2014.03.564
